Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rhox11
|
ENSMUSG00000051038.9 | reproductive homeobox 11 |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_100550980_100551317 | 25.18 |
Gm43466 |
predicted gene 43466 |
36379 |
0.11 |
chr17_65961618_65962124 | 16.84 |
Ankrd12 |
ankyrin repeat domain 12 |
10521 |
0.14 |
chr5_66918403_66918575 | 15.96 |
Gm43281 |
predicted gene 43281 |
2481 |
0.23 |
chr3_139885937_139886924 | 14.93 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr4_119461353_119461531 | 14.07 |
Zmynd12 |
zinc finger, MYND domain containing 12 |
16722 |
0.1 |
chr14_114352432_114352597 | 13.55 |
Gm19829 |
predicted gene, 19829 |
41711 |
0.21 |
chr4_13207002_13207160 | 13.38 |
Gm26250 |
predicted gene, 26250 |
59969 |
0.15 |
chr17_62607397_62607843 | 13.27 |
Gm25800 |
predicted gene, 25800 |
150500 |
0.04 |
chr6_5379663_5380044 | 12.96 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
3533 |
0.3 |
chr5_149495653_149495848 | 12.75 |
Gm2566 |
predicted gene 2566 |
7302 |
0.14 |
chr16_85092305_85093056 | 12.74 |
Gm49227 |
predicted gene, 49227 |
12569 |
0.2 |
chr19_18889230_18889551 | 12.57 |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
48753 |
0.16 |
chr5_17574085_17574813 | 12.43 |
Sema3c |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
168 |
0.97 |
chr16_41532566_41532885 | 12.17 |
Lsamp |
limbic system-associated membrane protein |
133 |
0.98 |
chr8_47242449_47242654 | 12.15 |
Stox2 |
storkhead box 2 |
135 |
0.97 |
chr3_51097482_51097714 | 11.92 |
Gm38246 |
predicted gene, 38246 |
6062 |
0.21 |
chr4_138504549_138504859 | 11.56 |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
50390 |
0.1 |
chr13_84285645_84285831 | 11.55 |
Gm46432 |
predicted gene, 46432 |
3922 |
0.2 |
chr1_94503928_94504626 | 11.43 |
Gm7895 |
predicted gene 7895 |
34390 |
0.22 |
chrX_100767602_100767791 | 11.32 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
26 |
0.97 |
chr15_30383087_30383401 | 11.19 |
Gm49283 |
predicted gene, 49283 |
45600 |
0.17 |
chr8_109464450_109464637 | 10.85 |
Pmfbp1 |
polyamine modulated factor 1 binding protein 1 |
29484 |
0.16 |
chr10_62865964_62866638 | 10.65 |
Tet1 |
tet methylcytosine dioxygenase 1 |
997 |
0.41 |
chr1_6733683_6734408 | 10.52 |
St18 |
suppression of tumorigenicity 18 |
825 |
0.73 |
chr13_83735761_83735940 | 10.49 |
Gm33366 |
predicted gene, 33366 |
2685 |
0.17 |
chr3_126609762_126610070 | 10.27 |
Gm43011 |
predicted gene 43011 |
9887 |
0.13 |
chr3_39047740_39047911 | 10.21 |
Gm43539 |
predicted gene 43539 |
38144 |
0.19 |
chr18_30736457_30736737 | 10.15 |
Gm41780 |
predicted gene, 41780 |
127707 |
0.06 |
chr8_54992339_54992525 | 10.10 |
Gm45265 |
predicted gene 45265 |
12853 |
0.14 |
chr6_40024235_40024578 | 10.07 |
Gm37995 |
predicted gene, 37995 |
2488 |
0.33 |
chr13_83737377_83737795 | 10.00 |
Gm33366 |
predicted gene, 33366 |
949 |
0.31 |
chr15_59040434_59041094 | 9.99 |
Mtss1 |
MTSS I-BAR domain containing 1 |
167 |
0.96 |
chr1_55665931_55666105 | 9.96 |
Plcl1 |
phospholipase C-like 1 |
36007 |
0.2 |
chr12_51400745_51400896 | 9.93 |
Scfd1 |
Sec1 family domain containing 1 |
21874 |
0.2 |
chr11_43548063_43548966 | 9.91 |
Ccnjl |
cyclin J-like |
19268 |
0.13 |
chr2_66041591_66042392 | 9.87 |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
52080 |
0.12 |
chr10_22609004_22609241 | 9.85 |
Slc2a12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
35889 |
0.16 |
chr12_70367356_70367615 | 9.76 |
Trim9 |
tripartite motif-containing 9 |
19871 |
0.17 |
chr1_38512263_38512473 | 9.70 |
Gm34727 |
predicted gene, 34727 |
24849 |
0.23 |
chr12_102554760_102554930 | 9.53 |
Chga |
chromogranin A |
124 |
0.96 |
chr10_126641848_126642305 | 9.53 |
Gm40797 |
predicted gene, 40797 |
21922 |
0.18 |
chr4_57638055_57638394 | 9.53 |
Pakap |
paralemmin A kinase anchor protein |
249 |
0.95 |
chr9_45651665_45651844 | 9.50 |
Gm22069 |
predicted gene, 22069 |
16942 |
0.18 |
chr2_91330284_91330767 | 9.50 |
Gm13787 |
predicted gene 13787 |
13664 |
0.15 |
chr5_66675580_66675740 | 9.43 |
Uchl1os |
ubiquitin carboxy-terminal hydrolase L1, opposite strand |
373 |
0.51 |
chr1_152040112_152040351 | 9.38 |
1700025G04Rik |
RIKEN cDNA 1700025G04 gene |
15061 |
0.25 |
chr6_77243554_77244106 | 9.36 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
908 |
0.69 |
chr4_98106522_98106958 | 9.31 |
Gm12691 |
predicted gene 12691 |
39859 |
0.19 |
chr19_37090377_37090698 | 9.30 |
Gm22714 |
predicted gene, 22714 |
58625 |
0.1 |
chr2_136670530_136670925 | 9.28 |
Gm36967 |
predicted gene, 36967 |
9234 |
0.23 |
chr14_121172063_121172458 | 9.20 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
70181 |
0.11 |
chr3_82406341_82406796 | 9.14 |
Map9 |
microtubule-associated protein 9 |
26495 |
0.24 |
chr11_39596506_39596789 | 9.14 |
Gm12131 |
predicted gene 12131 |
131065 |
0.06 |
chr2_57597721_57598247 | 9.12 |
Gm13532 |
predicted gene 13532 |
31244 |
0.18 |
chr4_128420200_128420503 | 9.05 |
Csmd2 |
CUB and Sushi multiple domains 2 |
56803 |
0.14 |
chr4_110287470_110287673 | 9.03 |
Elavl4 |
ELAV like RNA binding protein 4 |
44 |
0.99 |
chr18_45896851_45897467 | 9.03 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
650 |
0.79 |
chr7_79531276_79531635 | 9.01 |
Mir9-3hg |
Mir9-3 host gene |
3605 |
0.11 |
chr16_74397266_74397471 | 8.95 |
Robo2 |
roundabout guidance receptor 2 |
13544 |
0.25 |
chr1_14513900_14514131 | 8.90 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
203780 |
0.02 |
chr19_36534720_36535517 | 8.88 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19521 |
0.2 |
chr1_160351863_160352201 | 8.82 |
Rabgap1l |
RAB GTPase activating protein 1-like |
461 |
0.79 |
chr2_95232148_95232706 | 8.80 |
Gm13794 |
predicted gene 13794 |
161815 |
0.04 |
chr4_40014696_40014866 | 8.77 |
Gm26087 |
predicted gene, 26087 |
33223 |
0.16 |
chr15_44706767_44707004 | 8.77 |
Sybu |
syntabulin (syntaxin-interacting) |
40903 |
0.15 |
chr4_149220306_149220457 | 8.71 |
Kif1b |
kinesin family member 1B |
3137 |
0.22 |
chr11_32087496_32088333 | 8.68 |
Gm12108 |
predicted gene 12108 |
13314 |
0.2 |
chr18_16037927_16038695 | 8.57 |
Gm4835 |
predicted pseudogene 4835 |
49943 |
0.17 |
chr15_53901809_53902127 | 8.57 |
Samd12 |
sterile alpha motif domain containing 12 |
413 |
0.88 |
chr3_9173889_9174631 | 8.55 |
Zbtb10 |
zinc finger and BTB domain containing 10 |
76342 |
0.09 |
chr12_17048993_17049526 | 8.53 |
Gm48538 |
predicted gene, 48538 |
16154 |
0.17 |
chr1_86032315_86032658 | 8.51 |
Spata3 |
spermatogenesis associated 3 |
10381 |
0.11 |
chr4_109343206_109343384 | 8.47 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
42 |
0.98 |
chr12_51401071_51401222 | 8.40 |
Scfd1 |
Sec1 family domain containing 1 |
21548 |
0.2 |
chr4_142875107_142875410 | 8.39 |
Gm37624 |
predicted gene, 37624 |
84450 |
0.1 |
chr2_146061771_146062023 | 8.31 |
Cfap61 |
cilia and flagella associated protein 61 |
14646 |
0.25 |
chr4_142825785_142825983 | 8.30 |
Gm37624 |
predicted gene, 37624 |
35076 |
0.22 |
chr1_84694763_84694961 | 8.26 |
Mir5126 |
microRNA 5126 |
977 |
0.39 |
chrX_157051721_157051918 | 8.26 |
Gm22666 |
predicted gene, 22666 |
2136 |
0.38 |
chr18_50034876_50035293 | 8.24 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
4055 |
0.24 |
chr9_35411841_35412279 | 8.23 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
9068 |
0.16 |
chr10_85829043_85829227 | 8.22 |
Pwp1 |
PWP1 homolog, endonuclein |
359 |
0.58 |
chr6_138422642_138422962 | 8.22 |
Lmo3 |
LIM domain only 3 |
115 |
0.74 |
chr2_74426718_74427115 | 8.20 |
Lnpk |
lunapark, ER junction formation factor |
106190 |
0.05 |
chr13_11532120_11532294 | 8.18 |
Gm47487 |
predicted gene, 47487 |
8463 |
0.21 |
chr8_90536467_90536639 | 8.17 |
Gm45639 |
predicted gene 45639 |
138405 |
0.04 |
chr1_46830172_46830391 | 8.15 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
5618 |
0.22 |
chr8_48224421_48225088 | 8.12 |
Gm32842 |
predicted gene, 32842 |
46231 |
0.16 |
chr9_7960251_7960732 | 8.12 |
Yap1 |
yes-associated protein 1 |
5330 |
0.18 |
chr5_20521716_20521874 | 8.11 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
11705 |
0.27 |
chr3_34331331_34331482 | 8.09 |
Gm38505 |
predicted gene, 38505 |
20306 |
0.21 |
chr4_72800139_72800290 | 8.07 |
Aldoart1 |
aldolase 1 A, retrogene 1 |
52418 |
0.16 |
chr15_84621838_84622005 | 8.07 |
Gm34095 |
predicted gene, 34095 |
44804 |
0.12 |
chr5_30762944_30763095 | 8.06 |
Gm42764 |
predicted gene 42764 |
3987 |
0.15 |
chr5_120365955_120366154 | 8.03 |
Gm42654 |
predicted gene 42654 |
20086 |
0.15 |
chr13_110139484_110139641 | 8.00 |
Rab3c |
RAB3C, member RAS oncogene family |
140588 |
0.05 |
chr2_4436351_4436936 | 7.99 |
Gm13175 |
predicted gene 13175 |
30027 |
0.16 |
chr19_38054215_38055320 | 7.96 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr2_171641878_171642029 | 7.94 |
1700028P15Rik |
RIKEN cDNA 1700028P15 gene |
320178 |
0.01 |
chrX_72788888_72789096 | 7.94 |
Gabrq |
gamma-aminobutyric acid (GABA) A receptor, subunit theta |
36186 |
0.15 |
chr1_78141770_78141940 | 7.92 |
Pax3 |
paired box 3 |
54983 |
0.14 |
chr14_12190160_12190519 | 7.92 |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
396 |
0.87 |
chr6_63878047_63878198 | 7.89 |
Gm44075 |
predicted gene, 44075 |
94055 |
0.09 |
chr4_13409487_13409672 | 7.83 |
Gm11819 |
predicted gene 11819 |
35191 |
0.2 |
chr3_62348500_62348904 | 7.81 |
Arhgef26 |
Rho guanine nucleotide exchange factor (GEF) 26 |
7601 |
0.24 |
chr4_102240847_102240998 | 7.81 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
13820 |
0.28 |
chr4_96968887_96969075 | 7.78 |
Gm27521 |
predicted gene, 27521 |
51961 |
0.15 |
chr5_129762229_129762526 | 7.76 |
Psph |
phosphoserine phosphatase |
8778 |
0.1 |
chr10_117441743_117441911 | 7.76 |
Gm32141 |
predicted gene, 32141 |
5666 |
0.16 |
chr13_11268783_11268965 | 7.72 |
Gm25496 |
predicted gene, 25496 |
158024 |
0.04 |
chr4_87834348_87834670 | 7.71 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
28186 |
0.24 |
chr14_123513860_123514089 | 7.69 |
Nalcn |
sodium leak channel, non-selective |
112902 |
0.06 |
chr4_11762455_11762797 | 7.65 |
Cdh17 |
cadherin 17 |
4433 |
0.26 |
chr9_58084691_58085027 | 7.64 |
Ccdc33 |
coiled-coil domain containing 33 |
2790 |
0.19 |
chr5_131585577_131586049 | 7.63 |
Gm27266 |
predicted gene, 27266 |
7826 |
0.13 |
chr5_16002414_16002571 | 7.62 |
Gm43000 |
predicted gene 43000 |
4653 |
0.22 |
chr5_84417608_84417816 | 7.62 |
Epha5 |
Eph receptor A5 |
330 |
0.92 |
chr1_138496743_138496918 | 7.62 |
Gm28501 |
predicted gene 28501 |
18785 |
0.19 |
chr1_194160774_194160959 | 7.62 |
4930503O07Rik |
RIKEN cDNA 4930503O07 gene |
61893 |
0.15 |
chr13_72029205_72029633 | 7.60 |
Irx1 |
Iroquois homeobox 1 |
65696 |
0.13 |
chr6_58932530_58932858 | 7.59 |
Herc3 |
hect domain and RLD 3 |
25432 |
0.12 |
chr12_29240002_29240213 | 7.58 |
Gm6989 |
predicted gene 6989 |
77461 |
0.1 |
chr6_94631789_94631983 | 7.55 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
23639 |
0.17 |
chrX_49288183_49288615 | 7.49 |
Enox2 |
ecto-NOX disulfide-thiol exchanger 2 |
140 |
0.97 |
chr5_71010916_71011067 | 7.47 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
2693 |
0.43 |
chr17_90593854_90594144 | 7.42 |
Nrxn1 |
neurexin I |
5157 |
0.27 |
chr18_38212155_38213063 | 7.41 |
Pcdh1 |
protocadherin 1 |
556 |
0.57 |
chr13_34148695_34149213 | 7.41 |
Psmg4 |
proteasome (prosome, macropain) assembly chaperone 4 |
14010 |
0.11 |
chr10_46718374_46718662 | 7.41 |
Gm19994 |
predicted gene, 19994 |
48374 |
0.16 |
chr18_47536982_47537230 | 7.41 |
Gm5095 |
predicted gene 5095 |
629 |
0.77 |
chr8_48458356_48458774 | 7.40 |
Tenm3 |
teneurin transmembrane protein 3 |
96748 |
0.08 |
chr8_94996936_94997262 | 7.40 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
1438 |
0.29 |
chr4_23636552_23636896 | 7.40 |
Gm25978 |
predicted gene, 25978 |
9979 |
0.24 |
chr13_77892438_77892993 | 7.39 |
Pou5f2 |
POU domain class 5, transcription factor 2 |
132187 |
0.05 |
chr13_83872524_83872779 | 7.38 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
18557 |
0.19 |
chr10_95619676_95619912 | 7.37 |
Gm33336 |
predicted gene, 33336 |
12445 |
0.13 |
chr17_56693837_56694281 | 7.37 |
Ranbp3 |
RAN binding protein 3 |
2676 |
0.16 |
chr14_70659174_70659883 | 7.35 |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
284 |
0.85 |
chr2_91399750_91400118 | 7.34 |
Gm22071 |
predicted gene, 22071 |
7202 |
0.17 |
chr3_115856880_115857079 | 7.33 |
Dph5 |
diphthamide biosynthesis 5 |
30858 |
0.11 |
chr1_18758436_18758855 | 7.33 |
Gm5252 |
predicted gene 5252 |
50217 |
0.18 |
chr2_51082664_51083121 | 7.32 |
Rnd3 |
Rho family GTPase 3 |
66202 |
0.12 |
chr5_15577027_15578025 | 7.30 |
Gm21083 |
predicted gene, 21083 |
193 |
0.93 |
chr4_87739796_87740016 | 7.30 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
66388 |
0.14 |
chr6_55388308_55389212 | 7.30 |
6430584L05Rik |
RIKEN cDNA 6430584L05 gene |
8127 |
0.17 |
chr18_63513596_63513938 | 7.29 |
Gm22560 |
predicted gene, 22560 |
3872 |
0.18 |
chr14_49333997_49334148 | 7.28 |
Slc35f4 |
solute carrier family 35, member F4 |
19863 |
0.18 |
chr8_67974270_67974444 | 7.27 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
217 |
0.95 |
chr10_125961290_125962183 | 7.26 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
4432 |
0.33 |
chr9_28336751_28336923 | 7.26 |
Gm44316 |
predicted gene, 44316 |
44089 |
0.18 |
chr11_81860576_81860948 | 7.24 |
5530401A14Rik |
RIKEN cDNA 5530401A14 gene |
83 |
0.98 |
chr7_96212598_96213706 | 7.20 |
Tenm4 |
teneurin transmembrane protein 4 |
1481 |
0.42 |
chr2_75989132_75989283 | 7.20 |
Ttc30a1 |
tetratricopeptide repeat domain 30A1 |
7240 |
0.17 |
chr18_54820930_54821296 | 7.19 |
Gm33732 |
predicted gene, 33732 |
2676 |
0.26 |
chr11_20038729_20038886 | 7.19 |
Actr2 |
ARP2 actin-related protein 2 |
74060 |
0.09 |
chr6_12117902_12118084 | 7.14 |
Gm6578 |
predicted gene 6578 |
8410 |
0.23 |
chr3_66083540_66083691 | 7.13 |
Gm37822 |
predicted gene, 37822 |
3069 |
0.17 |
chr18_81830833_81831208 | 7.11 |
Gm30454 |
predicted gene, 30454 |
18996 |
0.19 |
chr3_98211005_98211156 | 7.10 |
Reg4 |
regenerating islet-derived family, member 4 |
11076 |
0.15 |
chr8_12916060_12916211 | 7.09 |
Mcf2l |
mcf.2 transforming sequence-like |
160 |
0.73 |
chr16_81175684_81175835 | 7.07 |
Ncam2 |
neural cell adhesion molecule 2 |
24938 |
0.24 |
chr7_118593842_118594498 | 7.05 |
B230311B06Rik |
RIKEN cDNA B230311B06 gene |
1654 |
0.28 |
chr10_4265598_4265939 | 7.04 |
Akap12 |
A kinase (PRKA) anchor protein (gravin) 12 |
612 |
0.77 |
chr16_79176820_79177259 | 7.04 |
Tmprss15 |
transmembrane protease, serine 15 |
85942 |
0.1 |
chr17_72194935_72195301 | 7.04 |
Gm19183 |
predicted gene, 19183 |
61140 |
0.15 |
chr2_93187957_93189155 | 7.02 |
Trp53i11 |
transformation related protein 53 inducible protein 11 |
635 |
0.76 |
chr12_118660886_118661037 | 7.01 |
Gm9267 |
predicted gene 9267 |
58284 |
0.12 |
chr5_66676056_66676249 | 6.94 |
Uchl1 |
ubiquitin carboxy-terminal hydrolase L1 |
61 |
0.57 |
chr18_9216377_9216790 | 6.94 |
Fzd8 |
frizzled class receptor 8 |
4420 |
0.27 |
chr4_22973344_22973526 | 6.93 |
1700025O08Rik |
RIKEN cDNA 1700025O08 gene |
35000 |
0.23 |
chr2_33786378_33786529 | 6.93 |
Mvb12b |
multivesicular body subunit 12B |
2306 |
0.31 |
chr7_36680111_36680262 | 6.93 |
Gm38285 |
predicted gene, 38285 |
15252 |
0.14 |
chr6_23876800_23877084 | 6.93 |
Cadps2 |
Ca2+-dependent activator protein for secretion 2 |
37521 |
0.2 |
chr14_11683845_11684071 | 6.91 |
Gm48602 |
predicted gene, 48602 |
83985 |
0.09 |
chr5_93266876_93267277 | 6.91 |
Ccng2 |
cyclin G2 |
181 |
0.95 |
chr12_29527021_29527799 | 6.91 |
Myt1l |
myelin transcription factor 1-like |
974 |
0.61 |
chr2_146330592_146331553 | 6.90 |
Gm14117 |
predicted gene 14117 |
25525 |
0.19 |
chr1_132739219_132739652 | 6.89 |
Nfasc |
neurofascin |
2322 |
0.3 |
chr15_72657768_72657941 | 6.87 |
Gm28020 |
predicted gene, 28020 |
63533 |
0.11 |
chrX_105392063_105392243 | 6.87 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
377 |
0.85 |
chr9_4514114_4514265 | 6.85 |
Gm23811 |
predicted gene, 23811 |
58166 |
0.15 |
chr13_78171338_78171906 | 6.85 |
3110006O06Rik |
RIKEN cDNA 3110006O06 gene |
8 |
0.97 |
chr2_62047440_62047741 | 6.84 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
945 |
0.69 |
chr4_25408403_25408554 | 6.84 |
Gm11894 |
predicted gene 11894 |
10871 |
0.22 |
chr13_104517962_104518622 | 6.82 |
2610204G07Rik |
RIKEN cDNA 2610204G07 gene |
166639 |
0.03 |
chr18_42629776_42629950 | 6.81 |
C030004G16Rik |
RIKEN cDNA C030004G16 gene |
7404 |
0.18 |
chr7_51749650_51749828 | 6.81 |
Gm7336 |
predicted gene 7336 |
3092 |
0.24 |
chr14_76033231_76033635 | 6.78 |
Gtf2f2 |
general transcription factor IIF, polypeptide 2 |
22568 |
0.18 |
chr18_39189575_39189773 | 6.78 |
Arhgap26 |
Rho GTPase activating protein 26 |
37694 |
0.19 |
chr8_87645474_87645645 | 6.76 |
4933402J07Rik |
RIKEN cDNA 4933402J07 gene |
81706 |
0.09 |
chr10_46827266_46827417 | 6.76 |
Gm25650 |
predicted gene, 25650 |
11166 |
0.24 |
chr18_43556808_43557020 | 6.76 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
10043 |
0.19 |
chr9_44457785_44458025 | 6.75 |
Upk2 |
uroplakin 2 |
2929 |
0.08 |
chr2_4420684_4420979 | 6.72 |
Frmd4a |
FERM domain containing 4A |
19360 |
0.18 |
chr7_71746628_71746779 | 6.72 |
Gm17988 |
predicted gene, 17988 |
28866 |
0.16 |
chr1_23705446_23705862 | 6.72 |
B3gat2 |
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) |
56099 |
0.15 |
chr3_27782113_27782447 | 6.71 |
Fndc3b |
fibronectin type III domain containing 3B |
70973 |
0.11 |
chr2_24428384_24428703 | 6.71 |
Pax8 |
paired box 8 |
5461 |
0.15 |
chr9_83806172_83806700 | 6.69 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
159 |
0.96 |
chr5_103939144_103939374 | 6.67 |
Klhl8 |
kelch-like 8 |
28000 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.2 | 30.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.3 | 17.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.6 | 14.4 | GO:0007412 | axon target recognition(GO:0007412) |
3.4 | 13.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
3.3 | 9.9 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
3.1 | 9.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.7 | 5.4 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.6 | 7.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
2.6 | 12.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.5 | 7.4 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.4 | 4.7 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
2.3 | 16.4 | GO:0097264 | self proteolysis(GO:0097264) |
2.1 | 8.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.1 | 16.7 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
2.0 | 8.1 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.0 | 2.0 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
1.9 | 21.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.9 | 7.6 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
1.9 | 5.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.8 | 5.5 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.8 | 5.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.8 | 5.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.8 | 8.8 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.7 | 7.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.7 | 5.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.7 | 5.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.7 | 5.1 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.7 | 6.8 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.6 | 4.8 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.6 | 4.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.5 | 3.0 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
1.5 | 3.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.5 | 6.0 | GO:0030091 | protein repair(GO:0030091) |
1.5 | 8.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.4 | 17.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.4 | 11.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.4 | 2.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.4 | 5.7 | GO:0050975 | sensory perception of touch(GO:0050975) |
1.4 | 2.8 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
1.4 | 6.8 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
1.3 | 4.0 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.3 | 6.7 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
1.3 | 10.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.3 | 7.6 | GO:0046958 | nonassociative learning(GO:0046958) |
1.2 | 1.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.2 | 3.7 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.2 | 3.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.2 | 3.6 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.2 | 11.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.2 | 8.2 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
1.1 | 6.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.1 | 3.3 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.1 | 2.2 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.1 | 3.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.1 | 5.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
1.1 | 4.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.1 | 2.1 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.1 | 3.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.0 | 2.1 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
1.0 | 4.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.0 | 3.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.0 | 3.9 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
1.0 | 1.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.0 | 4.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.0 | 3.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.0 | 2.9 | GO:0031223 | auditory behavior(GO:0031223) |
1.0 | 2.9 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.9 | 6.6 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.9 | 1.9 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.9 | 0.9 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.9 | 0.9 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.9 | 4.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.9 | 5.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.9 | 2.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.9 | 6.3 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.9 | 3.6 | GO:0030035 | microspike assembly(GO:0030035) |
0.9 | 0.9 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.9 | 3.5 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.9 | 2.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.9 | 3.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.8 | 1.7 | GO:1902896 | terminal web assembly(GO:1902896) |
0.8 | 0.8 | GO:0006848 | pyruvate transport(GO:0006848) |
0.8 | 2.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 1.7 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.8 | 5.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.8 | 4.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.8 | 2.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.8 | 2.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.8 | 6.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.8 | 2.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.8 | 5.5 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 6.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.8 | 3.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.8 | 4.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.8 | 2.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.8 | 3.0 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.8 | 0.8 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.7 | 0.7 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.7 | 1.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.7 | 2.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.7 | 3.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 10.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.7 | 1.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 | 2.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.7 | 0.7 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.7 | 2.9 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.7 | 0.7 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.7 | 0.7 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.7 | 2.8 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.7 | 3.4 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.7 | 2.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.7 | 2.7 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.7 | 0.7 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.7 | 4.8 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.7 | 3.3 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.7 | 2.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.7 | 0.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 3.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.7 | 0.7 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.7 | 2.6 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.6 | 10.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.6 | 1.9 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.6 | 1.3 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.6 | 1.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.6 | 0.6 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.6 | 0.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 1.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.6 | 1.9 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.6 | 1.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 1.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.6 | 3.1 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.6 | 6.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.6 | 0.6 | GO:0021885 | forebrain cell migration(GO:0021885) |
0.6 | 1.2 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.6 | 0.6 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.6 | 1.8 | GO:0021554 | optic nerve development(GO:0021554) |
0.6 | 1.8 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.6 | 1.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 0.6 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.6 | 1.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.6 | 3.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.6 | 5.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.6 | 1.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.6 | 2.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.6 | 0.6 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.6 | 2.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 2.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 1.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.5 | 1.1 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.5 | 1.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.5 | 1.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.5 | 1.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 1.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.5 | 1.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.5 | 2.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 9.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 2.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.5 | 1.0 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.5 | 1.5 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 1.5 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 1.0 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.5 | 1.0 | GO:0030070 | insulin processing(GO:0030070) |
0.5 | 3.6 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.5 | 1.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.5 | 1.0 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.5 | 1.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.5 | 2.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 4.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.5 | 2.0 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.5 | 1.5 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.5 | 1.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.5 | 2.0 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.5 | 0.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.5 | 0.5 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.5 | 2.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.5 | 1.9 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 4.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.5 | 3.8 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.5 | 0.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 2.3 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.5 | 2.3 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.5 | 1.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 1.4 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.5 | 2.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.5 | 1.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 0.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 3.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.5 | 1.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 3.1 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.4 | 0.9 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.4 | 1.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 1.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 1.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 1.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 0.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.4 | 0.9 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.4 | 1.3 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.4 | 5.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.4 | 1.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.4 | 1.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 2.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.4 | 1.7 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.4 | 1.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 1.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 0.4 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.4 | 1.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 1.7 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.4 | 0.4 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.4 | 1.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 5.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 1.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 1.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.4 | 2.9 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.4 | 1.2 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.4 | 1.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.4 | 1.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 2.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 1.6 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.4 | 2.1 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.4 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.4 | 0.8 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 2.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.4 | 0.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.4 | 0.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 1.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.4 | 2.8 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.4 | 4.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.4 | 2.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 1.2 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 5.9 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.4 | 0.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 2.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 1.9 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.4 | 1.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.4 | 3.8 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.4 | 3.0 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.4 | 1.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 0.4 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.4 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 0.4 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.4 | 1.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 1.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.4 | 2.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.4 | 2.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 1.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.4 | 0.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.4 | 1.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 2.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 1.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 0.7 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.4 | 1.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.4 | 1.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 1.4 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.4 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.4 | 1.1 | GO:0007567 | parturition(GO:0007567) |
0.3 | 1.0 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 9.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 1.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 1.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 2.8 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 1.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 1.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.3 | 0.3 | GO:0021557 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) |
0.3 | 0.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.3 | 1.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.3 | 4.7 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.3 | 0.7 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.3 | 1.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 1.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.3 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.3 | 0.3 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.3 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 2.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 1.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.3 | 0.3 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 0.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 0.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.3 | 2.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 0.6 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.3 | 1.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 0.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 1.6 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 1.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 0.3 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.3 | 0.9 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.3 | 0.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 0.9 | GO:0060923 | cardiac cell fate commitment(GO:0060911) cardiac muscle cell fate commitment(GO:0060923) |
0.3 | 0.9 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.3 | 0.6 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.3 | 0.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.9 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 0.9 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 0.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 1.5 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.3 | 0.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 0.3 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.3 | 0.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 0.9 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.3 | 1.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 4.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 1.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.3 | 1.5 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.3 | 2.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 1.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 1.8 | GO:0097061 | dendritic spine organization(GO:0097061) |
0.3 | 1.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 0.9 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.3 | 2.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.3 | 0.9 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 0.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 1.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 3.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 4.3 | GO:0060074 | synapse maturation(GO:0060074) |
0.3 | 0.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 1.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 0.6 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 0.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.8 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 1.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 3.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.3 | 0.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.3 | 2.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 0.5 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.3 | 0.8 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.3 | 2.4 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.3 | 1.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 0.8 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.3 | 1.1 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 2.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.3 | 4.2 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 1.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 1.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 3.6 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.3 | 1.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 1.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.3 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 1.0 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.3 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 2.8 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.3 | 0.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 0.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.3 | 0.5 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 1.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 1.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 0.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 0.7 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 1.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 0.7 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.7 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 1.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 0.2 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.7 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.2 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.2 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.2 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.2 | 6.6 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.2 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 1.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 1.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.4 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 1.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 0.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.7 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 2.5 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 0.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 2.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.9 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 1.3 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.2 | 0.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.2 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 0.9 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 2.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 2.0 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 0.7 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.7 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.2 | 1.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 0.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.6 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.2 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.2 | 0.8 | GO:0015824 | proline transport(GO:0015824) |
0.2 | 1.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 3.6 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.2 | 1.3 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 2.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 1.7 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.6 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 0.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 2.1 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.2 | 0.6 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 2.5 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 2.0 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 0.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 2.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 1.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.2 | GO:0090427 | embryonic nail plate morphogenesis(GO:0035880) activation of meiosis(GO:0090427) |
0.2 | 0.8 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 1.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 3.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.4 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.2 | 0.4 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.2 | 1.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 7.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.6 | GO:0008038 | neuron recognition(GO:0008038) |
0.2 | 1.0 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 0.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.6 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 0.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 1.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.2 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.6 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 15.7 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.2 | 1.3 | GO:0032224 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.6 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.2 | 0.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 0.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 3.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.2 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 4.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 1.3 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 1.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 3.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 9.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.5 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 1.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 0.2 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.2 | 0.8 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 0.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 0.3 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 1.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.3 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 1.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.6 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 1.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 1.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 0.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.2 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.8 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.6 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.2 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 0.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 1.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.5 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 0.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.2 | 0.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 1.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.9 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 2.3 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.6 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 1.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 2.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 1.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.1 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.1 | 1.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.3 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.6 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.3 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 1.4 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 0.3 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.6 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 1.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.4 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.1 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 1.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 1.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 1.1 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.1 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 8.3 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.5 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 3.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.4 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.3 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.1 | GO:2000729 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 2.6 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.4 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.9 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 0.5 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.3 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 1.7 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.5 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.1 | GO:2000855 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.1 | 1.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 1.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.3 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.4 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.1 | GO:0060897 | neural plate regionalization(GO:0060897) |
0.1 | 0.7 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.2 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 0.3 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.1 | 0.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.6 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.2 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.1 | 0.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.2 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.1 | 0.4 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 2.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.6 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.1 | 0.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.4 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 1.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.4 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.5 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 0.7 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.3 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.4 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.2 | GO:2000870 | progesterone secretion(GO:0042701) regulation of progesterone secretion(GO:2000870) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 1.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 1.6 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.6 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.5 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 1.4 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 1.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.7 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.2 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.6 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.1 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.1 | 0.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 1.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 2.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.1 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.1 | 0.1 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.1 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.3 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.1 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.1 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.1 | GO:2000822 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.1 | 0.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.9 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.2 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.1 | 2.3 | GO:0016358 | dendrite development(GO:0016358) |
0.1 | 0.1 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 0.9 | GO:0007431 | salivary gland development(GO:0007431) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 0.1 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.1 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.6 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.2 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.2 | GO:1902475 | ornithine transport(GO:0015822) L-alpha-amino acid transmembrane transport(GO:1902475) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.4 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 1.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.0 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.0 | 0.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 1.6 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0021544 | subpallium development(GO:0021544) striatum development(GO:0021756) |
0.0 | 0.0 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:0045472 | response to ether(GO:0045472) |
0.0 | 0.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.1 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.0 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.3 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.1 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.1 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.0 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.2 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.2 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.0 | 0.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.0 | 0.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.0 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.0 | 0.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.0 | 0.0 | GO:0071655 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.0 | 0.6 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.0 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.0 | 0.1 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.0 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.4 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.1 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.1 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.0 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.3 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 0.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.0 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 27.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.1 | 8.2 | GO:0042583 | chromaffin granule(GO:0042583) |
2.0 | 6.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
2.0 | 5.9 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.8 | 3.7 | GO:0097441 | basilar dendrite(GO:0097441) |
1.8 | 12.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.7 | 10.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.7 | 13.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.6 | 4.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.5 | 1.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.3 | 9.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.3 | 21.3 | GO:0030673 | axolemma(GO:0030673) |
1.2 | 3.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.2 | 4.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.2 | 11.9 | GO:0097449 | astrocyte projection(GO:0097449) |
1.2 | 4.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.1 | 3.4 | GO:0048179 | activin receptor complex(GO:0048179) |
1.0 | 6.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.0 | 7.0 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.8 | 24.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.8 | 13.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.8 | 2.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.7 | 3.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.7 | 0.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.7 | 1.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 1.5 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 2.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.7 | 7.8 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.7 | 3.5 | GO:0097433 | dense body(GO:0097433) |
0.7 | 2.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.7 | 2.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.6 | 26.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 3.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.6 | 5.0 | GO:0043194 | axon initial segment(GO:0043194) |
0.6 | 4.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.6 | 1.2 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.6 | 1.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.6 | 2.2 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 2.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 2.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 3.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 0.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 2.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 1.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 4.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 1.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 4.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 2.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 1.6 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 4.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 3.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 3.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 7.3 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.4 | 64.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.4 | 1.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 1.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.4 | 8.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 5.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 3.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.4 | 0.7 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 3.0 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 1.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 1.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 1.0 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 2.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 30.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 1.6 | GO:0002177 | manchette(GO:0002177) |
0.3 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 1.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 1.0 | GO:0032021 | NELF complex(GO:0032021) |
0.3 | 4.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 1.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 2.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 9.1 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.9 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 2.5 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 26.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.6 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 1.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 2.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 2.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 2.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 9.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 2.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 2.8 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 3.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 2.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 0.5 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 2.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 2.2 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.5 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 2.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 5.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 2.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.9 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 1.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 1.0 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 1.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.0 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.8 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.6 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.3 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.3 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 1.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.5 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 1.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.3 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 2.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 1.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 1.6 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 1.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.9 | GO:0001741 | XY body(GO:0001741) |
0.1 | 3.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 3.2 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 2.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.0 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.3 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 1.3 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 5.6 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 1.7 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 12.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
5.7 | 17.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.6 | 10.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
3.1 | 18.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.6 | 18.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.4 | 7.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.3 | 6.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
2.0 | 8.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.0 | 6.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.8 | 7.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.6 | 6.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.6 | 4.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.6 | 7.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.5 | 13.7 | GO:0038191 | neuropilin binding(GO:0038191) |
1.5 | 5.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.4 | 5.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.4 | 4.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.3 | 5.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.3 | 5.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.2 | 3.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.2 | 3.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.2 | 3.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.2 | 7.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.2 | 2.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.2 | 3.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.2 | 8.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.2 | 3.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.1 | 3.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.1 | 3.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.1 | 9.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.1 | 4.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.1 | 4.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.0 | 6.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.0 | 1.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.0 | 5.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.0 | 4.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.0 | 2.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.0 | 2.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.0 | 6.8 | GO:0003680 | AT DNA binding(GO:0003680) |
1.0 | 3.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.0 | 4.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.0 | 4.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.0 | 4.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.0 | 4.8 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.9 | 6.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.9 | 3.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.9 | 12.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.9 | 3.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.9 | 2.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.8 | 6.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.8 | 5.9 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.8 | 2.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.8 | 3.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.8 | 13.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.8 | 9.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.8 | 3.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.8 | 9.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.7 | 2.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 2.0 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 1.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.7 | 2.6 | GO:0015265 | urea channel activity(GO:0015265) |
0.6 | 12.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.6 | 1.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.6 | 3.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.6 | 1.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.6 | 3.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 4.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.6 | 7.8 | GO:0031404 | chloride ion binding(GO:0031404) |
0.6 | 7.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 8.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 1.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.6 | 1.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.6 | 1.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 2.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 2.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.5 | 5.9 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.5 | 2.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 0.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 2.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.5 | 1.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.5 | 4.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 15.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 1.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 1.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 2.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.5 | 1.5 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 2.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 1.8 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.4 | 2.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 2.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.4 | 1.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 2.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.4 | 1.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 2.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.4 | 2.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 0.9 | GO:0032564 | dATP binding(GO:0032564) |
0.4 | 1.7 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 4.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 3.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.4 | 2.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 7.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 2.1 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.4 | 1.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.4 | 1.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 2.0 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.4 | 10.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 3.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 1.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.4 | 3.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 1.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 0.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 1.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 3.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 5.7 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.4 | 11.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 1.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 4.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 1.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.3 | 1.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 2.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.3 | 1.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.9 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 2.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 2.9 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 3.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 1.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 1.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 0.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 1.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 1.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 3.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 2.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 2.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 2.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 0.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 1.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 2.9 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.3 | 0.8 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 0.8 | GO:0018590 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.3 | 1.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 1.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 0.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 2.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 1.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 0.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 5.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.5 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 3.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 0.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 1.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 9.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.7 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 1.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 1.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 1.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 6.3 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 0.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 2.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 4.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 0.8 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 1.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 0.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 5.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 3.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 2.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.7 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 1.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 1.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 2.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 1.7 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.4 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 1.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.9 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 4.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 2.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 2.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.8 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 2.0 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 1.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 3.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 2.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.1 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 0.3 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.6 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.4 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.5 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 1.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.1 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 0.8 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 1.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 2.9 | GO:0019111 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.1 | 1.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 1.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.2 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 0.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.3 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 2.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.0 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.4 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.0 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.1 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.2 | GO:0005272 | sodium channel activity(GO:0005272) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.9 | 2.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.9 | 14.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.7 | 7.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 4.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.5 | 4.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 6.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 2.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 6.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 9.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 4.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 0.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 10.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 1.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 6.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 3.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 9.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 2.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 8.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 7.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 2.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 2.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 4.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 2.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 2.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 5.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 1.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 7.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 2.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 3.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 4.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 29.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 2.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 18.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.2 | 1.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
1.1 | 12.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.9 | 8.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.7 | 9.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 7.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 9.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.6 | 9.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.6 | 15.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 14.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 6.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 1.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.5 | 9.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 15.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 20.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 2.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 5.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 5.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 4.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 0.4 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.4 | 3.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 1.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 0.8 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.4 | 4.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 1.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 1.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 1.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.3 | 3.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 3.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 4.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 0.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.3 | 4.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 8.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 3.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 5.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 0.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 2.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 3.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 1.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 3.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.2 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 7.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 1.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 3.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 6.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 2.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |